CLINICAL AND LABORATORY CORRELATES OF INTELLIGENCE LEVEL (IQ) IN PATIENTS WITH TYPE 2 DIABETES AND OBESITY

Cover Page


Cite item

Full Text

Abstract

Background: Level of intelligence influences compliance of diabetic patients and their active and conscious participation in self-care. A potential association between IQ and surrogate efficacy markers of type 2 diabetes mellitus (T2DM) treatment has not been studied in Russia.

Aim: To assess potential association between level of intelligence, glucose control, blood pressure (BP) control and obesity in T2DM patients.

Materials and methods: This cross-sectional study included 161 T2DM patients (28 males, 133 females) aged from 37 to 79 years with diabetes duration from 0,5 to 30 years. All patients underwent standard clinical and laboratory assessment, including glycated hemoglobin (HbA1c) measurement and were seen by a psychiatrist to diagnose possible depressive and cognitive disorders according to International Classification of Diseases-10 criteria. Each participant underwent psychometrical assessment, including Hachinski Ischemia Scale and a battery of cognitive tests. IQ was measured with Wechsler Adult Intelligence Scale (WAIS).

Results: Mean (± SD) IQ was 100,6 ± 14,9, which corresponds to average IQ. There was no correlation between IQ and patients age. There were no differences in IQ in T2DM patients from various bodyweight categories. Correlation between HbA1c and IQ in the whole group was non-significant (r = -0,13). Only patients with high and very high IQ (≥ 110) had lower HbA1c than the rest of the group (with IQ < 110): 8,1 ± 2,4 и 8,9 ± 1,9%, respectively (р < 0,05). Level of education did not influence glucose control, BP and body mass index (BMI); HbA1c, BMI and BP values in patients with primary and higher education was virtually similar.

Conclusion: Level of intelligence of T2DM patients does not contribute to risk factor control, such as bodyweight and BP. In majority of T2DM patients, glycemic control does not depend on their IQ and educational level; significantly better glucose control is achieved only by patients with higher IQs. The most important contributor to decrease of IQ in T2DM patients is not their age but rather chronic brain ischemia, i.e. cerebrovascular disease. 

About the authors

E. G. Starostina

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: elena.starostina59@yandex.ru

Starostina Elena Georgievna – MD, PhD, Professor, Chair of Endocrinology, Postgraduate Training Faculty

* 61/2–9 Shchepkina ul., Moscow, 129110, Russian Federation. Tel.: +7 (903) 797 84 88. E-mail: elena.starostina59@yandex.ru

Russian Federation

M. N. Volodina

Moscow Regional Research and Clinical Institute (MONIKI)

Email: elena.starostina59@yandex.ru

Volodina Marina Nikolaevna – Research Fellow, Department of Therapeutic Endocrinology

Russian Federation

A. E. Bobrov

Moscow Research Institute of Psychiatry – Affiliate of Federal Medical Research Centre for Psychiatry and Narcology

Email: bobrov2004@yandex.ru

Bobrov Alexey Evgen’evich – MD, PhD, Professor, Head of Department of Consultative and Telemedical Psychiatry

Russian Federation

References

  1. Anastasi A. Intelligence as a quality of behavior. In: Sternberg RJ, Detterman DK, editors. What is intelligence? Contemporary viewpoints on its nature and definition. Norwood, NJ: Ablex; 1986. p. 19–21.
  2. Анастази А, Урбина С. Психологическое тестирование. 7-е изд. СПб.: Питер; 2003. 688 с. (Anastazi A., Urbina S. Psychological testing. 7th ed. Saint Petersburg: Piter; 2003. 688 p. Russian).
  3. Бурлачук ЛФ, Морозов СМ. Словарь-справочник по психологической диагностике. Киев: Наукова думка; 1989. 200 с. (Burlachuk LF, Morozov SM. The Guide and Dictionary on diagnostics in psychology. Kiev: Naukova dumka; 1989. 200 p. Russian).
  4. Martínez-Leal R, Salvador-Carulla L, Gutiérrez-Colosía MR, Nadal M, Novell-Alsina R, Martorell A, González-Gordón RG, Mérida-Gutiérrez MR, Ángel S, Milagrosa-Tejonero L, Rodríguez A, García-Gutiérrez JC, Pérez-Vicente A, García-Ibáñez J, Aguilera-Inés F. Health among persons with intellectual disability in Spain: the European POMONA-II study. Rev Neurol. 2011;53(7):406–14.
  5. Taggart L, Coates V, Truesdale-Kennedy M. Management and quality indicators of diabetes mellitus in people with intellectual disabilities. J Intellect Disabil Res. 2013;57(12):1152–63.
  6. Dysch C, Chung MC, Fox J. How do people with intellectual disabilities and diabetes experience and perceive their illness? J Appl Res Intellect Disabil. 2012;25(1):39–49.
  7. Cardol M, Rijken M, van Schrojenstein Lantman-de Valk H. People with mild to moderate intellectual disability talking about their diabetes and how they manage. J Intellect Disabil Res. 2012;56(4):351–60.
  8. Reichard A, Stolzle H. Diabetes among adults with cognitive limitations compared to individuals with no cognitive disabilities. Intellect Dev Disabil. 2011;49(3):141–54.
  9. Rimmer JH, Yamaki K, Lowry BM, Wang E, Vogel LC. Obesity and obesity-related secondary conditions in adolescents with intellectual/developmental disabilities. J Intellect Disabil Res. 2010;54(9):787–94.
  10. de Winter CF, Magilsen KW, van Alfen JC, Penning C, Evenhuis HM. Prevalence of cardiovascular risk factors in older people with intellectual disability. Am J Intellect Dev Disabil. 2009;114(6):427–36.
  11. Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 1993;42(2): 341–4.
  12. Волчегорский ИА, Местер НВ, Зотова ОГ. Предикторы диабетической энцефалопатии. Журнал неврологии и психиатрии имени С.С. Корсакова. 2006;106(9):12–6. (Volchegorskiy IA, Mester NV, Zotova OG. [Predictors of diabetic encephalopathy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2006;106(9):12–6. Russian).
  13. Hsieh K, Rimmer JH, Heller T. Obesity and associated factors in adults with intellectual disability. J Intellect Disabil Res. 2014;58(9):851–63.
  14. Ordonez FJ, Rosety MA, Camacho A, Rosety I, Diaz AJ, Fornieles G, Garcia N, Rosety-Rodriguez M. Aerobic training improved low-grade inflammation in obese women with intellectual disability. J Intellect Disabil Res. 2014;58(6): 583–90.
  15. Pett M, Clark L, Eldredge A, Cardell B, Jordan K, Chambless C, Burley J. Effecting healthy lifestyle changes in overweight and obese young adults with intellectual disability. Am J Intellect Dev Disabil. 2013;118(3):224–43.
  16. de Winter CF, Hermans H, Evenhuis HM, Echteld MA. Associations of symptoms of anxiety and depression with diabetes and cardiovascular risk factors in older people with intellectual disability. J Intellect Disabil Res. 2015;59(2):176–85.
  17. Grondhuis SN, Aman MG. Overweight and obesity in youth with developmental disabilities: a call to action. J Intellect Disabil Res. 2014;58(9):787–99.
  18. Miller J, Kranzler J, Liu Y, Schmalfuss I, Theriaque DW, Shuster JJ, Hatfield A, Mueller OT, Goldstone AP, Sahoo T, Beaudet AL, Driscoll DJ. Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J Pediatr. 2006;149(2):192–8.
  19. Cournot M, Marquié JC, Ansiau D, Martinaud C, Fonds H, Ferrières J, Ruidavets JB. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology. 2006;67(7):1208–14.
  20. Yu ZB, Han SP, Cao XG, Guo XR. Intelligence in relation to obesity: a systematic review and meta-analysis. Obes Rev. 2010;11(9):656–70.
  21. Singh-Manoux A, Czernichow S, Elbaz A, Dugravot A, Sabia S, Hagger-Johnson G, Kaffashian S, Zins M, Brunner EJ, Nabi H, Kivimäki M. Obesity phenotypes in midlife and cognition in early old age: the Whitehall II cohort study. Neurology. 2012;79(8):755–62.
  22. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77(5):461–8.
  23. Anstey KJ, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011;12(5):e426–37.
  24. Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol. 2012;8(4):189–202.
  25. Mirowsky J. Cognitive decline and the default American lifestyle. J Gerontol B Psychol Sci Soc Sci. 2011;66 Suppl 1:i50–8.
  26. Burkhalter TM, Hillman CH. A narrative review of physical activity, nutrition, and obesity to cognition and scholastic performance across the human lifespan. Adv Nutr. 2011;2(2):201S–6S.
  27. Belsky DW, Caspi A, Goldman-Mellor S, Meier MH, Ramrakha S, Poulton R, Moffitt TE. Is obesity associated with a decline in intelligence quotient during the first half of the life course? Am J Epidemiol. 2013;178(9):1461–8.
  28. Phan TL, Curran JL, Datto GA. Evaluation of intelligence in an adolescent bariatric population. Surg Obes Relat Dis. 2013;9(4):574–9.
  29. Панасюк АЮ. Адаптированный вариант методики Д. Векслера. М.: НИИ психиатрии МЗ РСФСР; 1973. 79 с. (Panasyuk AYu. Adapted Wechsler’s methods. Moscow: NII psikhiatrii MZ RSFSR; 1973. 79 p. Russian).
  30. Старостина ЕГ, Володина МН. Церебральная ишемия как маркер депрессии и когнитивных нарушений при сахарном диабете 2 типа. Сахарный диабет. 2010;(4):117–8. (Starostina EG, Volodina MN. [Cerebral ischemia as a marker of depression and cognitive disorders in patients with type 2 diabetes mellitus]. Sakharnyy diabet. 2010;(4):117–8. Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Starostina E.G., Volodina M.N., Bobrov A.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies